baber/WOPTO huggingface dataset:
Patent NZ-536149-A (NZ)
Title: Using extensible markup language to create word processing documents that can be manipulated by XML enabled applications
Inventor: JONES BRIAN M
IPC: G06F40/00
Filed: 2003-04-24
Abstract: A schema encoded on a computer-readable medium is for a word processor markup language. This provides codes within a document that specifies how parts of the document are to be interpreted by an application. The schema comprises a properties element; a styles element; a body element, wherein the body element comprises: a paragraph element; a text run element including text that is the text content of a word-processor document and is defined by a single tag; and a table element. (62) Divided Out of 525484
Patent NZ-536518-A (NZ)
Title: Method for surface treatment of clay, ceramic or cementitious articles
Inventor: MUNCH-LAURSEN THOMAS
IPC: B28B1/093
Filed: 2003-04-22
Abstract: A method for the surface treatment of clay, ceramic or cementitious articles, especially roofing tiles, comprising providing a hardenable, water-containing mass (1) shaped in the form of the article, then covering an exposed surface area of the article with a flexible membrane (3), such as a plastics film, having an upper-surface and a smooth under-surface, such that the latter is in intimate contact with and conforms to the contours of that surface area of the article, thereby providing a membrane-covered area of the article, vibrating the membrane-covered area of the article, for example via a vibrator head (6) applied to a rigid plate (5) overlaid on the membrane, such that vibration is transmitted through the membrane, to the surface of the article, and either removing the membrane then hardening the article, or at least partially hardening the article with the membrane in place.
Patent NZ-537363-A (NZ)
Title: Bovine genotyping method to determine if milk contains beta-casein A1 or A2
Inventor: LEE MICHAEL AH
IPC: C12N5/073
Filed: 2003-05-23
Abstract: Disclosed is a method for determining whether a bovine animal possesses a gene encoding for the protein beta-casein A1 or a gene encoding for the protein beta-casein A2 by testing the DNA of the animal for the presence of at least one DNA marker for either of the beta-casein A1 or beta-casein A2 genes, where the at least one DNA marker is the SNP AC000061 of SEQ ID No:21 located in a gene encoding for the protein alphas2-casein. The method can be used to produce milk substantially free of beta-casein A1.
Patent NZ-537410-A (NZ)
Title: Extended release formulations of clarithromycin that minimise adverse effects and provide at least equivalent to tablet or liquid formulations
Inventor: CRAMPTON SHERI L
IPC: A61K9/22
Filed: 1998-03-06
Abstract: Described is a pharmaceutical composition for extended release of clarithromycin in the gastrointestinal tract, to be administered orally, comprising clarithromycin, which, when administered once a day, induces a statistically significantly lower degree of fluctuation value for the clarithromycin concentration in plasma compared with an equal dosing of the immediate release composition of clarithromycin administered twice a day, while maintaining exposure (AUC0-24) substantially equivalent to the immediate release composition of clarithromycin. The composition further induces a statistically significant lower degree of fluctuation value in plasma compared with that of the controlled release formulation containing clarithromycin, a water soluble alginate salt, a complex salt of alginic acid, and an organic carboxylic acid, and, which releases clarithromycin so that after a regimen of a single 1000 mg dose on day 1 and a multiple dose regimen of 1000 mg on days 3, 4 and 5, the Cmax is about 2.45 mu g/ml, the Cmin is about 0.70 mu g/ml, the Tmax is about 8.6 hours, the AUC0-24 is about 39.6 mu g h/ml, and the fluctuation index is about 1.11. The pharmaceutical composition also has an improved taste perversion compared with an immediate release formulation containing clarithromycin when administered to a patient.
Patent NZ-539049-A (NZ)
Title: Indazoles, benzothiazoles, and benzoisothiazoles and preparation and uses thereof
Inventor: TEHIM ASHOK
IPC: A61P25/28
Filed: 2003-09-25
Abstract: Disclosed are indazole, benzothiazole and benzoisothiazole ligands of Formulas I, II, III, or IV, wherein A is an indazolyl, benzothiazolyl, isobenzothiazolyl group according to sub formulas (a) to (c), respectively, X is O or S and R1, R2 R3, R4, R5, Ar, and Het are as defined in the specification. When said compound is of Formula I the indazolyl group of group A is attached via its 3, 4, or 7 position, the benzothiazolyl group of group A is attached via its 4 or 7 position, or the isobenzothiazolyl group of group A is attached via its 3, 4, or 7 position. This field of ligands relates to nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain for example, psychotic diseases, dementia and in anti-intoxication therapy.
Patent NZ-543103-A (NZ)
Title: Method of brake disk attachment to cast wheel
Inventor: DRAGE KEVIN LINANE
IPC: F16D65/12
Filed: 2004-02-25
Abstract: A wheel and floating rotor disc brake assembly including a wheel having a hub with at least one projecting portion, the projecting portion having a slot formed at least a part way around thereof, the slot lying in a plane substantially normal to the axis of rotation of the wheel and parallel to the plane of rotation of the wheel. The disc brake rotor has at least one radially inward protruding tab, adapted to locate in and be fixed to the hub slot via pin elements. Axial spring clips or thrust washers are retained between the hub and the disc brake rotor by the pin elements, thereby permitting a limited degree of axial movement, or float between them.
Patent NZ-545058-A (NZ)
Title: Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
Inventor: FREYNE EDDY JEAN EDGARD
IPC: C07D487/04
Filed: 2004-07-12
Abstract: Disclosed is a compound of formula (I), wherein R2 represents C3-7cycloalkyl, phenyl, a 4-, 5-, 6- or 7-membered monocyclic heterocycle containing at least one heteroatom selected from O, S or N, benzoxazolyl or a radical of formula (a-1); and the remaining substituents are as defined in the specification. Also disclosed are processes for preparing the compounds, which are GSK3 modulators useful in the treatment of diseases or conditions such as Alzheimer's disease, cancer, diabetes, inflammatory diseases, bipolar disorder, depression and pain.
Patent NZ-549999-A (NZ)
Title: Cover strip and attached sliding door or window track
Filed: 2006-09-20
Abstract: A door or window track, for supporting passage of a sliding window or door, includes a pair of opposed walls and an open top. A cover strip 25, formed from a one-piece plastic moulding or metal extrusion, consists of a top wall and depending legs which abut with adjoining walls of the door or window track.
Patent NZ-553987-A (NZ)
Title: Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
Inventor: FEINSTEIN ELENA
IPC: A61K48/00
Filed: 2005-09-27
Abstract: Provided is a double stranded RNA compound having the structure: 5' (N)x - Z 3' (antisense strand); 3' Z' - (N')y 5' (sense strand); wherein each of N and N' is an unmodified ribonucleotide or a 2'-O-Me sugar modified ribonucleotide and each consecutive ribonucleotide is joined to the next ribonucleotide by a covalent bond; wherein each of x and y is an integer from 19 to 40; wherein each of Z and Z' may be present or absent, but if present is dTdT and is covalently attached at the 3' terminus of the strand in which it is present; wherein alternating ribonucleotides in both the antisense strand and sense strands are 2'-O-Me sugar modified ribonucleotides; wherein a 2'-O-Me sugar modified ribonucleotide is present at both the 5' terminus and 3' terminus of the antisense strand and an unmodified ribonucleotide is present at both the 5' terminus and the 3' terminus of the sense strand; and wherein (N)x comprises the sequence ugaagggugaaauauucuc. This and related compositions can be used to treat renal failure and other disorders.
Patent NZ-561692-A (NZ)
Title: Mop with lever operable to squeeze and tilt mop pad
Inventor: LIN ZHU XUE
Filed: 2007-09-18
Abstract: A mop (1) is provided that has a generally elongate mop pad (5) that is squeezable by a user operable squeezing mechanism (7). When the mop pad is squeezed, it is folded about its centre to form a generally "U" shape. The squeezing mechanism (7) then squeezes the opposed faces against each other. The squeezing mechanism (7) cooperates with the mop pad (5) to also tilt the mop pad (5) from a position where the mop pad (5) is extending generally orthogonal to a longitudinal axis of a mop handle (3), to a position where the mop pad (5) is inclined relative to the longitudinal axis of the mop handle (3) and so when the mop handle (3) is inclined to a planar surface to be cleaned, the mop pad (5) can better engage with the planar surface to be cleaned than if the mop pad (5) were not tilted.
Patent NZ-562562-A (NZ)
Title: Hydrogenated benzo(C)thiophene derivatives as immunomodulators
Inventor: BOLLI MARTIN
IPC: A61K31/38
Filed: 2006-03-20
Abstract: Disclosed is a hydrogenated benzo(C)thiophene derivative of Formula (I), or a stereoisomer, salt, solvate, or polymorph thereof, wherein A is -CONH-CH2-, -CO-CH=CH-, -CO-CH2CH2-, -CO-CH2-O-, -CO-CH2-NH-, or an oxadiazole, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the compound for treating diseases and disorders associated with an activated immune system, such as rejection of transplanted organs selected from kidney, liver, heart and lung; graft-versus-host diseases brought about by stem cell transplantation; autoimmune syndromes selected from rheumatoid arthritis, multiple sclerosis, psoriasis, psoriatic arthritis, Crohn's disease, and Hashimoto's thyroiditis; and atopic dermatitis. Also disclosed is the intermediate compound of formula (II), or a stereoisomer, salt, solvate, or polymorph thereof, wherein R8 is hydroxyl, C1-5alkoxy, or methyl, and wherein the other substituents are as for Formula (I).
Patent NZ-565855-A (NZ)
Title: Aerated compositions comprising hydrophobin
Inventor: COX ANDREW RICHARD
IPC: A23L27/60
Filed: 2007-01-05
Abstract: Disclosed is an aerated composition having an overrun of at least 10% and comprising water and an emulsified fat phase wherein at least 50% by weight of the fat is liquid at 5°C, characterized in that the composition comprises hydrophobin.
Patent NZ-567022-A (NZ)
Title: Topical film-forming monophasic formulations
Inventor: BROWN MARC BARRY
IPC: A61K47/10
Filed: 2006-09-14
Abstract: Disclosed is a pharmaceutical formulation capable of forming a film on topical application, said formulation comprising a preparation of a pharmaceutical, a solvent thereof, a film forming agent, and a propellant, wherein the formulation is monophasic and the pharmaceutical is present in a substantially saturating amount therein, under conditions of use, and wherein the pharmaceutical is present at least 80% saturation, wherein said film-forming agent is selected from the group consisting of polyvinyl pyrrolidone, polyvinyl alcohol, acrylic polymers, acrylic copolymers, methacrylate polymers, methacrylate copolymers, poly (vinyl acetate), cellulose based polymers and cellulose based co-polymers in an amount of between 0.1 and 40 percent w/w inclusive.
Patent NZ-576527-A (NZ)
Title: Improved modular building components and methods
Inventor: RUNDLE GAVIN
IPC: E06B1/04
Filed: 2009-04-28
Abstract: An architectural fitting of the type including windows and doors, the fitting comprising a generally rectangular frame (1) housing an infill panel (2) of glass or the like, the frame being formed of at least two lengths of a channel shaped extrusion (3) having a recessed base (5) and two extending flanges (6) at the inner (7) and outer (8) edges thereof, wherein the recessed base includes one or a plurality of negative keyways (9) for captively receiving an intermediate locking plate (l0) such that the locking plate can co-operate to lock two adjacent frames by slidable engagement so as to remain captive and fully contained within the two adjacent recessed bases.
Patent NZ-579803-A (NZ)
Title: Pre-filled applicator device for delivering medicine to a body cavity
Inventor: SWICK PAUL B
IPC: A61D7/00
Filed: 2009-09-21
Abstract: A device 10 for delivering a medicated product to a bodily cavity comprises a barrel member 12 having a distal end and a proximal end, a plunger 16 sized to extend into the proximal end of the barrel member 12, a cap 14 and retaining means. The barrel member 12 is sized to contain the medicated product, and includes a plurality of internal threads. The cap 14 is adapted to move between a sealing position, in which the cap 14 is positioned adjacent to the barrel member 12 and seals the distal end of the barrel member 12, and a dispensing position, in which the cap 14 is moved in a direction away from the barrel member 12. The cap 14 includes an opening 50 sized to allow the medicated product to flow through the cap 14 when the cap 14 is in the dispensing position. The cap 14 includes a plurality of external threads sized to threadedly mate with the internal threads of the barrel member 12. The internal threads of the barrel member 12 and the external threads of the cap 14 cooperate with each other so as to allow the cap 14 to move from the sealing position to the dispensing position. The retaining means retain the cap 14 on the barrel member 12 when the cap 14 is in the dispensing position.
Patent NZ-582536-A (NZ)
Title: Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
Inventor: ZHAO MATTHEW MANGZHU
IPC: C07H5/04
Filed: 2008-07-17
Abstract: Disclosed is a method of preparing a compound of formula I wherein the substituents are defined in the specification: or a salt thereof, which comprises contacting a compound of formula II wherein the substituents are defined in the specification: with a base under conditions sufficient to provide the compound of formula I.
Patent NZ-582789-A (NZ)
Title: Image guided plaque ablation using ultrasound waves
Inventor: APPELMAN YOLANDE
IPC: A61N7/02
Filed: 2008-06-24
Abstract: A system for non-invasively elevating the temperature of tissue by ultrasound energy waves comprising at least one ultrasound delivery device adapted to deliver ultrasound energy waves to a focal point of targeted tissue, a temperature monitoring device for monitoring the temperature of targeted tissue, and a controller for steering and controlling the ultrasound delivery device to deliver ultrasound energy waves at a focal point less than about 15 mm3 and intensity of focus of the ultrasound energy waves in the range of about 500 W/cm' to about 3000 W/cm' to elevate the temperature of targeted tissue to a desired temperature.
Patent NZ-588232-A (NZ)
Title: Improved cooking gas burner assembly
Inventor: ROSSI CARLO ANTONIO
IPC: F24C3/08
Filed: 2005-10-27
Abstract: A burner assembly includes a cap (220) and a distributor (30) on which the cap (220) is mounted, the distributor (30) including an internal and an external crown of flame ports, and at least one cross lighting passage (37) between the respective crowns. The cap (220) includes a through-going aperture (222) which is adapted to be positioned over said cross lighting passage (37) when said cap (220) and distributor (30) are assembled.
Patent NZ-591206-A (NZ)
Title: Sensing force during partial and total knee replacement surgery
Inventor: FISHER MICHAEL G
IPC: A61F2/38
Filed: 2009-08-20
Abstract: 591206 Systems, devices, and methods are provided for measuring forces in the space of a knee during surgery. Such forces can be caused by tension in the ligaments of the knee. A femoral member is engaged with a distal femur (DF). While the knee is flexed, partially extended, or fully extended, a force sensor (100) and a gauge shim can be placed in the gap between the femoral member and the tibial plateau to measure the forces therebetween. The force sensor provides an accurate and quantifiable measurement of force, making knee replacement surgery and ligament tension balancing more accurate, standardized and repeatable. The force sensor comprises an elongate housing which comprises a thin force sensing distal portion and a proximal handle portion (150).
Patent NZ-594433-A (NZ)
Title: Control system for the climate in a spatial environment for organisms, spatial environment adapted thereto, control system and program therefor
Inventor: KAMP PETRUS GERARDUS HENDRIKUS
IPC: A01G9/24
Filed: 2010-02-02
Abstract: 594433 Controls for the climate in a space (35) such as a building such as greenhouse, barn, office and house or such as a vehicle such as car, ship and aircraft. An organism (10) therein forms part of the control system for the climate in the space, and the controls comprise the at least co-controlling of the temperature of this organism. Use is here at made of at the level of the organism supplied, unsaturated, in dependence of directing by the controls conditioned air. The controls depart from a temperature registration of the organism and climate registration (temperature, air humidity and -speed) in the space (by sensors (2a, 2b, 2c)) at at least two respective height levels (22a, 22b, 22c). With an at a first level established relation between climate parameters and organism temperature an expectation in organism temperature is determined on the basis of a change in the climate parameters at the second level. By determination or establishment of difference between desired and measured plant temperature and determination or establishment of heat flow, conditioned air can be supplied better and more direct.
Patent NZ-600576-A (NZ)
Title: Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
Inventor: BARONI MARCO
IPC: A61K31/496
Filed: 2010-12-13
Abstract: The disclosure relates to (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives of the general formula (I), where A, W, n, and R2 are as defined in claim 1. The disclosure moreover relates to the method for preparing said derivatives and to the therapeutic use of said derivatives. Compounds of the disclosure include: Methyl 6-{ 3-[2-(4-benzofuran-7-yl-3,6-dihydro-2H-pyridin-1-yl)-2-oxoethyl]-3,8-diazabicyclo[3.2.1]oct-8-yl} nicotinate; 5-{ (3S,5R)-4-[2-(4-benzo[b]thiophen-4-yl-3,6-dihydro-2H-pyridin-1-yl)-2-oxoethyl]-3,5-dimethylpiperazin-1-yl} pyridine-2-carboxylic acid; 1-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)-3,6-dihydro-2H-pyridin-1-yl]-2-[8-(5-fluoropyrimidin-2-yl)-3,8-diazabicyclo[3.2.1]oct-3-yliethanone and 1-(4-benzo[b]thiophen-7-yl-3,6-dihydro-2H-pyridin-1-yl)-2-[4-(7-chloro-quinolin-4-yl)piperazin-1-yl]ethanone. The compounds disclosed act upon the p75NTR receptor. the disclosed compounds may be used in the treatment of neurodegenerative, cardiovascular and inflammatory conditions.
Patent NZ-600749-A (NZ)
Title: Cell-permeabilising peptides and polypeptides for microbial cells
Inventor: ATTWOOD GRAEME TREVOR
IPC: C07K4/04
Filed: 2008-09-25
Abstract: 600749 Discloses an isolated peptide comprising at least 90% of the amino acid sequence KKLIIILLLLILLLSI, KKKLIIILLLLILLLSI or KKIIIILLLLILLLISI. A method of permeabilising Methanobrevibacter ruminantium cell membrane by contacting the peptide to the cell and methods of producing the peptide and fusion molecules.
Patent NZ-600929-A (NZ)
Title: Combinations comprising a fungicidal strain and an active compound
Inventor: SCHOFL ULRICH
IPC: A01N63/02
Filed: 2008-09-16
Abstract: 600929 Disclosed is a fungicidal composition for controlling phytopathogenic harmful fungi, comprising 1) a fungicidal strain (I) selected from a) the Bacillus substilis strain with NRRL Accession No. B-21661, and b) the Bacillus pumilus strain with NRRL Accession No. B-30087, or a mutant of these strains having all the identifying characteristics of the respective strain, or a metabolite produced by the respective strain that exhibits activity against plant pathogenic fungi, and 2) at least one other fungicide selected from the group consisting of metrafenone, dodine free base, guazatine-acetate, prohexadione calcium and N-(cyclopropylmethoxyimino-(6-trifluoromethyl-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide; in a synergistically effective amount.
Patent NZ-601692-A (NZ)
Title: Temperature differential engine device
Inventor: LIU ANGFENG
IPC: F01D1/00
Filed: 2011-02-09
Abstract: 601692 Disclosed is a temperature differential engine device for transferring thermal energy, extracted from a natural environment, into mechanical energy. The device includes a steam turbine (1), a heat absorber (2), a thermally insulated countercurrent heat exchanger (3), a circulating pump (4), and a refrigerating system (5) which are interconnected to constitute a closed circulating system filled with low-boiling-point working fluid. The steam turbine and the heat absorber constitute a low-density-medium heat-absorbing working system, wherein the working fluid is gaseous. The circulating pump and the refrigerating system constitute a high-density-medium refrigerating-circulating system, wherein the working fluid is liquid. The working fluid, in a gaseous state within the heat absorber, absorbs heat from a heat source, where it then flows to the countercurrent heat exchanger. The working fluid passes from a hot end (A) to a cold end (B) where the working fluid condenses into liquid. Upon exiting the countercurrent heat exchanger the fluid is cooled in the refrigerating system before re-entering the countercurrent heat exchanger travelling from the cold end to the hot end and becoming gaseous again. The result of the working fluid passing through the countercurrent heat exchanger is such that the temperature of the gaseous working fluid at the exit point is less that the temperature of the gaseous working fluid at the entry point of the countercurrent heat exchanger. The slightly cooler gaseous working fluid is then used to drive the steam turbine before being heated again in the heat absorber.
Patent NZ-601710-A (NZ)
Title: Paper finishing process
Inventor: MAGRIN ARMANDO
IPC: C14C11/00
Filed: 2011-01-11
Abstract: Disclosed is a process for applying a finishing paper material (3) on a leather or fabric support material (2). The disclosure notes that current processes for applying a finishing paper result in the paper wrinkling or getting damaged thus affecting the aesthetics of the final product. The process comprises a first buttering of glue (4) on a surface (2a) of the support material (2). The finishing material (3) is positioned on the support material (2). The finishing material (3) and support material (2) are ironed and perched. After the steps of ironing and perching, a second buttering of glue (4) is applied. The process is completed with a finishing step.
Patent NZ-603434-A (NZ)
Title: Process and plant for producing hot metal
Inventor: JEAN-PAUL NEPPER
IPC: C21B13/00
Filed: 2011-05-19
Abstract: 603434 A process and plant for the production of hot metal is disclosed. Granular raw materials containing iron oxide are partially reduced to a reduced mixture with a carbonaceous reducing agent in a fluidized bed reactor (13) at a temperature of at least 850°C. The reduced mixture is feed via a discharge system, possibly after separation of the magnetic and non-magnetic components by hot magnetic separation (30), to a smelting reduction unit (31). To optimize the energy consumption, the reduced mixture is cooled to 600°C to 800°C in a heat exchanger apparatus (21) before being supplied to the smelting unit, wherein a preheated process gas (11) is used as cooling medium then fed (24) to the fluidized bed reactor.